T1	PROC 46 78	Estudio en fase 2, multicéntrico
T2	PROC 96 110	ensayo abierto
T3	DISO 233 252	Enfermedad de Crohn
#1	AnnotatorNotes T3	C0010346; Crohn Disease; Disease or Syndrome
T4	PROC 276 304	Estudio Fase 2 Multicéntrico
T5	DISO 442 461	Enfermedad de Crohn
#2	AnnotatorNotes T5	C0010346; Crohn Disease; Disease or Syndrome
T6	DISO 487 506	Enfermedad de Crohn
#3	AnnotatorNotes T6	C0010346; Crohn Disease; Disease or Syndrome
T7	PROC 788 804	test de embarazo
#4	AnnotatorNotes T7	C0032976; Pregnancy Tests; Diagnostic Procedure
T8	CHEM 911 921	medicación
#5	AnnotatorNotes T8	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T9	PROC 190 206	administraciones
#6	AnnotatorNotes T9	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T10	PROC 399 413	administración
#7	AnnotatorNotes T10	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T11	PROC 116 177	observar la eficacia a largo plazo, seguridad y tolerabilidad
T12	CHEM 210 217	ABT 494
#8	AnnotatorNotes T12	C4308782; ABT-494; Organic Chemical · Pharmacologic Substance
T13	PROC 331 378	observar la eficacia, seguridad y tolerabilidad
T14	CHEM 417 424	ABT-494
#9	AnnotatorNotes T14	C4308782; ABT-494; Organic Chemical · Pharmacologic Substance
T15	PROC 962 976	procedimientos
#10	AnnotatorNotes T15	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T16	Date 13 17	2015
T17	Date 137 150	a largo plazo
T18	LIVB 221 228	sujetos
#11	AnnotatorNotes T18	C0681850; Study Subject; Group
T19	Date 379 392	a largo plazo
T20	LIVB 428 437	pacientes
#12	AnnotatorNotes T20	C0030705; Patients; Patient or Disabled Group
T21	LIVB 537 544	sujetos
#13	AnnotatorNotes T21	C0681850; Study Subject; Group
T22	Duration 601 611	52 semanas
T24	LIVB 662 668	sujeto
#14	AnnotatorNotes T24	C0681850; Study Subject; Group
T25	LIVB 691 703	investigador
#15	AnnotatorNotes T25	C0035173; Research Personnel; Professional or Occupational Group
T26	LIVB 739 764	sujetos del sexo femenino
#16	AnnotatorNotes T26	C0043210; Woman; Population Group
T27	LIVB 876 882	Sujeto
#17	AnnotatorNotes T27	C0681850; Study Subject; Group
T29	PHYS 796 804	embarazo
#18	AnnotatorNotes T29	C0032961; Pregnancy; Organism Function
T30	PHYS 839 850	embarazadas
#19	AnnotatorNotes T30	C0032961; Pregnancy; Organism Function
T23	Neg_cue 887 889	no
T28	Observation 895 903	conforme
#20	AnnotatorNotes T28	C3714738; Compliance; Finding (?)
A1	Status T8 History_of
A2	Status T15 History_of
A3	Assertion T28 Negated
#21	AnnotatorNotes T1	C0282460; Phase 2 Clinical Trials; Research Activity + C1096776; Multicenter Study; Research Activity
#22	AnnotatorNotes T4	C0282460; Phase 2 Clinical Trials; Research Activity + C1096776; Multicenter Study; Research Activity
#23	AnnotatorNotes T2	C1709323; Open Label Study; Research Activity 
#24	AnnotatorNotes T13	C0511730; Identify product efficacy and safety issues; Health Care Activity + C3274448; Tolerability Study; Research Activity
#25	AnnotatorNotes T17	C0443252; Long-term; Temporal Concept
#26	AnnotatorNotes T19	C0443252; Long-term; Temporal Concept
#27	AnnotatorNotes T11	C0023981; Longitudinal Studies; Research Activity + C1705187; Safety Study; Research Activity + C3274448; Tolerability Study; Research Activity
T31	Neg_cue 645 652	ninguna
T32	Observation 662 683	sujeto es considerado
A4	Assertion T32 Negated
#28	AnnotatorNotes T32	C1302261; Patient eligible for clinical trial; Finding (?)
R1	Overlap Arg1:T11 Arg2:T17	
T33	Quantifier_or_Qualifier 180 189	repetidas
#29	AnnotatorNotes T33	C0205341; Repeat; Functional Concept
R2	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T33	
R3	Used_for Arg1:T12 Arg2:T9	
R4	Experiences Arg1:T18 Arg2:T9	
R5	Experiences Arg1:T18 Arg2:T3	
R6	Overlap Arg1:T13 Arg2:T19	
R7	Used_for Arg1:T14 Arg2:T10	
R8	Experiences Arg1:T20 Arg2:T10	
R9	Experiences Arg1:T20 Arg2:T5	
T34	Observation 557 578	completado el estudio
#30	AnnotatorNotes T34	C2732579; Completion of clinical trial; Finding
R11	Overlap Arg1:T34 Arg2:T22	
R12	Negation Arg1:T31 Arg2:T32	
R13	Experiences Arg1:T24 Arg2:T32	
R14	Experiences Arg1:T26 Arg2:T7	
R15	Experiences Arg1:T26 Arg2:T29	
T35	Result_or_Value 773 781	positivo
#31	AnnotatorNotes T35	C1446409; Positive; Finding
R16	Has_Result_or_Value Arg1:T7 Arg2:T35	
T36	Observation 817 850	considerando quedarse embarazadas
#32	AnnotatorNotes T36	C0032992; Pregnancy, Planned; Finding
R17	Before Arg1:T36 Arg2:T30	
R18	Experiences Arg1:T26 Arg2:T36	
T37	PROC 866 873	estudio
#33	AnnotatorNotes T37	C0008976; Clinical Trials; Research Activity
R19	Overlap Arg1:T30 Arg2:T37	
R20	Overlap Arg1:T36 Arg2:T37	
R21	Has_Quantifier_or_Qualifier Arg1:T27 Arg2:T28	
R22	Negation Arg1:T23 Arg2:T28	
R23	Overlap Arg1:T28 Arg2:T8	
T38	Quantifier_or_Qualifier 933 945	concomitante
#34	AnnotatorNotes T38	C0521115; Simultaneous; Temporal Concept
R24	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T38	
R25	Experiences Arg1:T27 Arg2:T15	
R26	Negation Arg1:T23 Arg2:T15	
A5	Assertion T15 Negated
R27	Overlap Arg1:T28 Arg2:T15	
T39	PROC 992 999	Estudio
#35	AnnotatorNotes T39	C0008976; Clinical Trials; Research Activity
R28	Overlap Arg1:T15 Arg2:T39	
A6	Status T39 History_of
T40	PROC 571 578	estudio
A7	Status T40 History_of
#36	AnnotatorNotes T40	C0008976; Clinical Trials; Research Activity
R29	Has_Duration_or_Interval Arg1:T40 Arg2:T22	
R10	Overlap Arg1:T29 Arg2:T37	
R30	Overlap Arg1:T7 Arg2:T37	
R31	Overlap Arg1:T35 Arg2:T37	
A8	Experiencer T18 Patient
A9	Experiencer T20 Patient
A10	Experiencer T21 Patient
A11	Experiencer T24 Patient
A12	Experiencer T25 Other
A13	Experiencer T26 Patient
A14	Status T30 Future
A15	Experiencer T27 Patient
